Manipulating the metazoan mitochondrial genome with targeted restriction enzymes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18653897.
- Also identified by DOI 10.1126/science.1160226 and PMC identifier 2754248.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
High copy number and random segregation confound genetic analysis of the mitochondrial genome. We developed an efficient selection for heritable mitochondrial genome (mtDNA) mutations in Drosophila, thereby enhancing a metazoan model for study of mitochondrial genetics and mutations causing human mitochondrial disease. Targeting a restriction enzyme to mitochondria in the germline compromised fertility, but escaper progeny carried homoplasmic mtDNA mutations lacking the cleavage site. Among mutations eliminating a site in the cytochrome c oxidase gene, mt:CoI(A302T) was healthy, mt:CoI(R301L) was male sterile but otherwise healthy, and mt:CoI(R301S) exhibited a wide range of defects, including growth retardation, neurodegeneration, muscular atrophy, male sterility, and reduced life span. Thus, germline expression of mitochondrial restriction enzymes creates a powerful selection and has allowed direct isolation of mitochondrial mutants in a metazoan.
Medical subject headings
- DNA Restriction Enzymes
- DNA, Mitochondrial
- Deoxyribonucleases, Type II Site-Specific
- Drosophila melanogaster
- Genome, Mitochondrial
- Mutation